Form D · Biotechnology

Rakuten Medical, Inc.

San Diego, CA · CIK 0001595215

Offering snapshot reported Oct 6, 2026 · SEC filing

Reported sold
$8.97M
Offering amount: $8.97M
Investors reported
14
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 16, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 6, 2026Initial$8,974,943No comparison14SEC filing
Apr 13, 2026Initial$111,522,289No comparison26SEC filing
May 7, 2025Amendment$1,865,406$496,856vs Feb 5, 202514SEC filing
Feb 5, 2025Initial$1,368,550No comparison15SEC filing
Mar 28, 2024Initial$4,161,200No comparison15SEC filing
Oct 4, 2023Amendment$2,189,000-$3,005,350vs Jul 7, 202220SEC filing
Sep 1, 2023Initial$104,816,348No comparison15SEC filing
Dec 28, 2022Initial$70,000,000No comparison4SEC filing
Jul 7, 2022Initial$5,194,350No comparison31SEC filing
Jul 29, 2021Initial$166,010,712No comparisonNot reportedSEC filing
Jan 14, 2021Initial$15,000,000No comparison1SEC filing
Jan 5, 2021Initial$90,000,000No comparison6SEC filing
Jul 15, 2020Initial$791,700No comparison1SEC filing
Aug 7, 2019Initial$99,999,997No comparison1SEC filing
Nov 7, 2018Amendment$149,999,993$0vs Nov 7, 20184SEC filing
Nov 7, 2018Amendment$149,999,993$0vs Aug 23, 20184SEC filing
Aug 23, 2018Initial$149,999,993No comparison4SEC filing
Jul 21, 2017Initial$15,079,974No comparison45SEC filing
Oct 5, 2016Amendment$55,199,998$15,199,998vs Mar 10, 20168SEC filing
Mar 10, 2016Initial$40,000,000No comparison2SEC filing
Jul 30, 2015Initial$4,249,999No comparison3SEC filing
Jan 23, 2015Initial$8,455,175No comparison8SEC filing

Offering details

Securities
Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-599980

Source: Form D, filed Oct 6, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Abhijit Bhatia Executive
Merrill Biel Director, Executive
Louise Chang Executive
David Chao Director
Hassan Danesi Executive
Mazen Darwazah Director
Mazen Darwazeh Director
Carlos Garcia Executive
Miguel Garcia Guzman Director
Kentaro Hyakuno Director
Dana Johnson Executive
Eiichi Kaga Director
Brenton Keath Executive
Hiroyuki Kodama Executive
Minami Maeda Executive
Anthony Manibusan Executive
Agatha Martindale Executive
Ann Mc Guire Executive
Hiroshi Mikitani Director
Maeda Minami Executive
Hiroshi Mori Director
Nitin Nohria Director
Tiffany Piecewicz Executive
Scott Salka Director, Executive
Suzane San Executive
Toshiaki Suzuki Executive
Hiroshi Takasawa Director
Ken Takeshita Director
Amy Thorne Executive
Takashi Toraishi Director, Executive
Christophe Weber Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
6885 Flanders Drive Suite 1000
San Diego, CA, 92121
Phone: 858-925-5619